vemurafenib (Q2616764): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 1 language: The description in Wikidata changed) |
(Changed label, description and/or aliases in nl: Label in wikidata changed) |
||
| (4 intermediate revisions by the same user not shown) | |||
| label / nl | label / nl | ||
vemurafenib | |||
| label / sl | label / sl | ||
Vemurafenib | |||
| label / sv | label / sv | ||
vemurafenib | |||
| aliases / sv / 0 | aliases / sv / 0 | ||
Zelboraf | |||
| aliases / sv / 1 | aliases / sv / 1 | ||
PLX4032 | |||
| aliases / sv / 2 | aliases / sv / 2 | ||
RG7204 | |||
| aliases / sv / 3 | aliases / sv / 3 | ||
N-{3-[3-Karbonyl-5-(4-klorofenyl)-1H-pyrrolo[2,3-b]pyridin]-2,4-difluorofenyl}propan-1-sulfonamid | |||
| description / sv | description / sv | ||
kemisk förening | |||
Latest revision as of 22:22, 17 March 2023
chemical compound
- PLX4032
- RG7204
- Zelboraf®
- Zelboraf
- BRAF(V600E) Kinase Inhibitor RO5185426
- Vemurafenib
- PLX 4032
- N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | vemurafenib |
chemical compound |
|